BG107088A - Agent for treating hepatitis c - Google Patents

Agent for treating hepatitis c

Info

Publication number
BG107088A
BG107088A BG107088A BG10708802A BG107088A BG 107088 A BG107088 A BG 107088A BG 107088 A BG107088 A BG 107088A BG 10708802 A BG10708802 A BG 10708802A BG 107088 A BG107088 A BG 107088A
Authority
BG
Bulgaria
Prior art keywords
treating hepatitis
agent
alkaloid
medicament
producing
Prior art date
Application number
BG107088A
Other languages
Bulgarian (bg)
English (en)
Inventor
Wassil NOWICKY
Original Assignee
Wassil NOWICKY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wassil NOWICKY filed Critical Wassil NOWICKY
Publication of BG107088A publication Critical patent/BG107088A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/21Interferons [IFN]
    • A61K38/212IFN-alpha
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BG107088A 2000-03-22 2002-09-12 Agent for treating hepatitis c BG107088A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AT0048100A AT408719B (de) 2000-03-22 2000-03-22 Mittel zur behandlung von hepatitis c
PCT/AT2001/000076 WO2001070203A2 (fr) 2000-03-22 2001-03-20 Agent de traitement de l'hepatite c

Publications (1)

Publication Number Publication Date
BG107088A true BG107088A (en) 2003-05-30

Family

ID=3674939

Family Applications (1)

Application Number Title Priority Date Filing Date
BG107088A BG107088A (en) 2000-03-22 2002-09-12 Agent for treating hepatitis c

Country Status (17)

Country Link
JP (1) JP2003527414A (fr)
KR (1) KR20020087045A (fr)
CN (1) CN1416347A (fr)
AT (1) AT408719B (fr)
AU (1) AU2001239000A1 (fr)
BG (1) BG107088A (fr)
BR (1) BR0107211A (fr)
CA (1) CA2389173A1 (fr)
EA (1) EA200200584A1 (fr)
HR (1) HRP20020367A2 (fr)
IL (1) IL149314A0 (fr)
IS (1) IS6360A (fr)
MA (1) MA25509A1 (fr)
MX (1) MXPA02004993A (fr)
NO (1) NO20022253L (fr)
PL (1) PL365000A1 (fr)
WO (1) WO2001070203A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH695417A5 (de) * 2001-11-15 2006-05-15 Ddr Wassyl Nowicky Dipl Ing Verfahren zur Umsetzung von Alkaloiden.
EP1459753A1 (fr) 2003-03-18 2004-09-22 Nowicky, Wassyl, Dipl.-Ing. DDr. Dérivés quaternaires de chelidonine et d'alkaloides, procédé pour leur préparation et leur utilisation dans la préparation de médicaments
WO2008039179A1 (fr) * 2006-09-26 2008-04-03 Addiction Research Institute, Inc. Compositions de traitement de l'hépatite c et procédés d'utilisation des compositions de traitement de l'hépatite c
CN106343303A (zh) * 2015-07-13 2017-01-25 张如安 灭杀乙肝病毒的饮料
CN106109538A (zh) * 2016-07-29 2016-11-16 桂林淮安天然保健品开发有限公司 治疗丙肝的药物组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3128018A1 (de) * 1981-07-13 1983-04-07 Wassyl 1060 Wien Nowicky "verfahren zum diagnostizieren und fuer die therapeutische behandlung von tumoren und/oder infektioesen krankheiten verschiedenster art unter praeparativem einsatz von alkaloid-verbindungen bzw. deren salze"
US4816462A (en) * 1982-05-18 1989-03-28 Nowicky Wassili Method for diagnosing and for the therapeutic treatment of tumors and/or infectious diseases of different types with alkaloid-compounds
US4970212A (en) * 1982-05-18 1990-11-13 Nowicky Wassili Method of treating human illnesses which compromise the ability to mount an effective immunological response
PT93772A (pt) * 1989-04-17 1991-01-08 Searle & Co Processo para a preparacao de composicoes para o tratamento de neoplasias, contendo um agente anti-neoplastico, por exemplo doxorubicina e um agente protector para reduzir os efeitos secundarios, por exemplo carbetimer

Also Published As

Publication number Publication date
PL365000A1 (en) 2004-12-27
AT408719B (de) 2002-02-25
WO2001070203A2 (fr) 2001-09-27
MA25509A1 (fr) 2002-07-01
NO20022253D0 (no) 2002-05-10
MXPA02004993A (es) 2003-10-14
HRP20020367A2 (en) 2004-02-29
AU2001239000A1 (en) 2001-10-03
WO2001070203A3 (fr) 2002-09-06
IS6360A (is) 2002-04-24
EA200200584A1 (ru) 2003-06-26
CA2389173A1 (fr) 2001-09-27
BR0107211A (pt) 2004-01-06
ATA4812000A (de) 2001-07-15
JP2003527414A (ja) 2003-09-16
CN1416347A (zh) 2003-05-07
KR20020087045A (ko) 2002-11-21
NO20022253L (no) 2002-05-10
IL149314A0 (en) 2002-11-10

Similar Documents

Publication Publication Date Title
MX9709867A (es) Derivados de pirimidina condensados con un anillo heterociclico, composiciones que contienen los mismos, y uso de los mismos.
YU57599A (sh) Primena derivata fumarne kiseline
PL337126A1 (en) Novel compounds
IL145005A0 (en) 4-OXO-4, 7-DIHYDRO-THIENO[2,3-b] PYRIDINE-5-CARBOXAMIDES AS ANTIVIRAL AGENTS
WO2001047928A3 (fr) Nouveaux imidazo[1,3,5]triazinones et leur utilisation
BG106343A (en) Carboxylic acid amides, medicaments containing these compounds and the use and production thereof
EA004302B9 (ru) β-КАРБОЛИНОВЫЕ ЛЕКАРСТВЕННЫЕ ПРОДУКТЫ
BG108426A (en) Novel sulfonic acid derivatives
MY119303A (en) New manufacturing process of metoprolol
MX9700245A (es) Nuevo compuesto quimico, su preparacion y su empleo como medicamento.
BG107088A (en) Agent for treating hepatitis c
IL142793A0 (en) Process for the production of a shaped article
CA2256514A1 (fr) Utilisation veterinaire d'un derive de pleuromutiline
IL146811A0 (en) Novel method for preparing benzoperhydroisoindole compounds
MXPA02002355A (es) Procedimiento para la produccion de derivados de acido naftiridin-3-carboxilico.
NZ515685A (en) Use of riluzole for the treatment of multiple sclerosis
NZ332687A (en) use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
MXPA02006674A (es) Proceso novedoso para la preparacion de alfa-(2,4-disulfofenil)-n-ter-butilnitrona y las sales farmaceuticamente aceptables de la misma.
AU2001254712A1 (en) Use of organophosphorous compounds for producing a medicament for treating infections
HU9502821D0 (en) Process for the manufacture of aminomethanephosphonic acid
PL353926A1 (en) Process for the preparation of 2-cyanopyridines
NZ308024A (en) The reaction product of alkaloids of Chelidonium maius L. with thiophosphoric acid triaziridide is used as radiation treatment medicine
MY127737A (en) Novel process for the preparation of pyrazolopyrimidinones
WO2002018389A3 (fr) Thienopyrimidines
IL149713A0 (en) Process for the production of trifluormethylacetophenones